MMBG Investment Advisors’s Moderna MRNA Stock Holding History

MMBG Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200K	Buy	+2,860	New	+$148K	0.02%	177
2024 Q3	–	Sell	-2,860	Closed	-$340K	–	169
2024 Q2	$340K	Hold	2,860	–	–	0.04%	130
2024 Q1	$305K	Hold	2,860	–	–	0.03%	147
2023 Q4	$284K	Hold	2,860	–	–	0.03%	146
2023 Q3	$295K	Hold	2,860	–	–	0.04%	137
2023 Q2	$352K	Hold	2,860	–	–	0.04%	133
2023 Q1	$439K	Hold	2,860	–	–	0.06%	123
2022 Q4	$514K	Sell	2,860 -1,430	-33%	-$234K	0.07%	115
2022 Q3	$507K	Hold	4,290	–	–	0.07%	116
2022 Q2	$613K	Buy	4,290 +1,430	+50%	+$204K	0.08%	107
2022 Q1	$493K	Hold	2,860	–	–	0.05%	122
2021 Q4	$726K	Buy	+2,860	New	+$836K	0.07%	111

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

MMBG Investment Advisors's MRNA Position: Q2 2026 in Review

MMBG Investment Advisors opened a new position in Moderna (MRNA) in Q2 2026: 2,860 shares worth $200K. The stake represents 0.02% of the portfolio and ranks #177 among its holdings. This is a return to the name: MMBG Investment Advisors previously reported a position in MRNA as recently as Q2 2024.

MMBG Investment Advisors first reported a position in MRNA in Q4 2021 and has held it in 12 quarters since. The position peaked at $726K in Q4 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

MMBG Investment Advisors held 2,860 shares of Moderna worth $200K as of Q2 2026.
Moderna was a new MMBG Investment Advisors position in Q2 2026.
Moderna made up 0.02% of MMBG Investment Advisors's portfolio in Q2 2026, its #177 holding.
MMBG Investment Advisors first reported a position in Moderna in Q4 2021 and has held it in 12 quarters since.
MMBG Investment Advisors's Moderna position peaked at $726K in Q4 2021.
784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on MMBG Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.